FUNDAMENTAL OF HIV TESTING AND PREVENTION


Date: Feb 25, 2020 09:30 AM - Feb 26, 2020 02:40 PM

Fee

$0.00

CE Hours

3.00

CE Units

0.300

Registration closes on Apr 25, 2020 11:30 PM

Activity Type

Knowledge

Target Audience(s)

Pharmacist

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

Registration closes on Apr 25, 2020 at 11:30 PM

Registration Closed  

Objectives

  • Describe PrEP, including the goal(s) of therapy.
  • Identify risk factors for PrEP eligibility.
  • Explain the requirements for PrEP initiation.
  • List the monitoring parameters for patients on PrEP
  • Describe the role of community pharmacists in the management of PrEP

Speaker(s)/Author(s)

OLUFUNMI ARIYO, PHARM.D, AAHIVP

Activity Number

0010-9999-20-005-L02-P
Date: 02/25/20
Time: 12:30 PM - 01:30 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe the evolving DHHS treatment guidelines for when to start patients on ARV therapy
  • Explain the HIV life cycle and treatment targets
  • Describe adherence strategies to optimize HIV viral suppression
  • Identify lifestyle and behaviors that can impact adherence

Speaker(s)/Author(s)

CHRISTOPHER ROBERSON, MS, ACRN, AAHIVS

Activity Number

0010-9999-20-006-L02-P
Date: 02/25/20
Time: 01:30 PM - 02:00 PM

CE Hours

0.50
Registration Closed  

Registration closes on Apr 25, 2020 at 11:30 PM

Registration Closed  

Objectives

  • Describe PrEP, including the goal(s) of therapy
  • Identify risk factors for PrEP eligibility
  • Explain the requirements for PrEP initiation
  • List the monitoring parameters for patients on PrEP
  • Describe the role of community pharmacists in the management of PrEP

Speaker(s)/Author(s)

OLUFUNMI ARIYO, PHARM.D, AAHIVP

Activity Number

0010-9999-20-005-L02-P
Date: 02/26/20
Time: 12:30 PM - 01:30 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe the evolving DHHS treatment guidelines for when to start patients on ARV therapy
  • Explain the HIV life cycle and treatment targets
  • Describe adherence strategies to optimize HIV viral suppression
  • Identify lifestyle and behaviors that can impact adherence

Speaker(s)/Author(s)

CHRISTOPHER ROBERSON, MS, ACRN, AAHIVS

Activity Number

0010-9999-20-006-L02-P
Date: 02/26/20
Time: 01:30 PM - 02:00 PM

CE Hours

0.50
Registration Closed